Closed-loop sonothermogenetic control of CAR T cells for metronomic brain cancer therapy
Zamat, A.; Kim, C.; Sridhar, S.; Fabrega, S.; Sen, R.; Campbell, N.; Oliver, S. A.; Zha, Z.; Thiveaud, C.; Kulaksizoglu, E.; Brienen, M.; Okada, H.; Woodworth, G.; Arvanitis, C.; Kwong, G. A.
Show abstract
Achieving durable CAR T cell responses against primary brain tumors and metastases requires strategies that enable intracranial control of therapy to overcome the barriers of solid tumor treatment without compromising safety. Here, we show that closed-loop sonothermogenetics enables remote regulation of CAR T cell therapeutic activity through the intact skull. Using MR-guided focused ultrasound with closed-loop temperature feedback, we modulate CAR T cells engineered with a genetically encoded thermal bioswitch to achieve metronomic activation in the brain without lasting adverse effects on healthy brain tissue. In murine models of brain cancer, metronomic production of NKG2D T cell engagers by intratumoral CAR T cells overcomes antigen heterogeneity in breast cancer brain metastasis and myeloid-derived immunosuppression in glioblastoma to drive antitumor responses. Our findings support the use of closed-loop sonothermogenetics for spatial and temporal control of CAR T cell therapies targeting solid brain tumors.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.